JBM Healthcare Announces FY2025 Interim Results JBM (Healthcare) Limited Nov 19, 2024 20:51 HKT/SGT Read More
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus Nov 19, 2024 14:30 HKT/SGT Read More
Beat The Silent Disease of Osteoporosis with LAC, Before It's Too Late! LAC Global Nov 18, 2024 13:00 HKT/SGT Read More
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) Eisai Nov 15, 2024 16:33 HKT/SGT Read More
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Eisai Nov 15, 2024 13:31 HKT/SGT Read More
Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism Mitsubishi Corporation Nov 15, 2024 11:32 HKT/SGT Read More
ニュートン バイオキャピタル、⽇本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、⽇本初の投資を発表 Newton Biocapital Nov 14, 2024 11:00 JST Read More
Femto Technologies Announces Third Quarter 2024 Financial Results Femto Technologies Inc Nov 14, 2024 07:00 HKT/SGT Read More
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program NEC Corporation Nov 13, 2024 11:05 HKT/SGT Read More
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 NEC Corporation Nov 08, 2024 09:31 HKT/SGT Read More
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting NEC Corporation Nov 07, 2024 10:40 HKT/SGT Read More
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem" Eisai Nov 05, 2024 10:35 HKT/SGT Read More
JBM Healthcare Issues Positive Profit Alert JBM (Healthcare) Limited Nov 04, 2024 15:00 HKT/SGT Read More
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status Eisai Nov 01, 2024 12:56 HKT/SGT Read More
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference Eisai Oct 31, 2024 12:56 HKT/SGT Read More
Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD) Eisai Oct 31, 2024 10:33 HKT/SGT Read More